Aquestive Therapeutics (AQST) to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Feb 21, 2023 08:00AM
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Feb 21, 2023 08:00AM
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for AQST-109 Epinephrine Sublingual Film at American Academy of Allergy, Asthma, and Immunology (AAAAI) Feb 21, 2023 08:00AM
Aquestive Therapeutics (AQST) Reports Positive EPIPHAST II Trial Data for AQST-109 Sep 27, 2022 07:04AM
Aquestive Therapeutics Announces Positive EPIPHAST II Trial Data for AQST-109 When Compared to EpiPen® Sep 27, 2022 07:00AM


Sep 27, 2022 07:00AM Aquestive Therapeutics Announces Positive EPIPHAST II Trial Data for AQST-109 When Compared to EpiPen®
Sep 12, 2022 04:01PM Aquestive Therapeutics (AQST) Announces Expert Allergy Scientific Advisory Board
Sep 12, 2022 04:01PM Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
Sep 12, 2022 04:01PM Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
Jul 11, 2022 08:00AM Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film
Jul 11, 2022 08:00AM Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film